Healthcare

Cynata Therapeutics Limited (ASX:CYP) has built its technology strategy around Cymerus, a platform designed to manufacture mesenchymal stromal cells using induced pluripotent stem cells. The approach aims to address a key challenge in cell therapy: producing consistent cell products at commercial scale.

Chimeric Therapeutics Limited (ASX:CHM) is a clinical-stage biotechnology company focused on developing cell therapies for difficult-to-treat cancers. Its current priority programme, CHM CDH17, is a CAR-T therapy designed to target cadherin-17, a protein found on the surface of selected gastrointestinal cancers.

Immutep Limited (ASX:IMM) is a biotechnology company focused on immune checkpoint technology, particularly the LAG-3 pathway. The company’s main asset, eftilagimod alfa or efti, is designed to activate antigen-presenting cells through the MHC Class II pathway to support immune responses against tumours.

Botanix Pharmaceuticals Limited (ASX:BOT) is a dermatology-focused biotechnology company developing commercial opportunities around Sofdra (sofpironium) gel. The product received US Food and Drug Administration approval in June 2024 for primary axillary hyperhidrosis, a condition involving excessive underarm sweating.

CurveBeam AI Limited (ASX:CVB) is a medical imaging company focused on technologies that assess bones and joints under natural weight-bearing conditions. Its HiRise system is designed as a weight-bearing computed tomography (CT) scanner that captures images while patients stand.

ImpediMed Limited (ASX:IPD) is a medical-device company focused on bioimpedance spectroscopy technology. Its SOZO platform measures fluid levels in the body using a small electrical current and is primarily used for lymphoedema assessment following cancer treatment.

BPH Global Limited (ASX:BP8) is reshaping its operating focus around seaweed trading and related health and consumer applications. The company has moved away from its former China bird’s nestBusinessand is building activity around seaweed supply, exports andDownstreamproduct development.